{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:31:30Z","timestamp":1788993090216,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.isci.2020.101303","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T10:15:37Z","timestamp":1592648137000},"page":"101303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Current Status of COVID-19 Therapies and Drug Repositioning Applications"],"prefix":"10.1016","volume":"23","author":[{"given":"Ozlem","family":"Altay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyas","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4476-0971","authenticated-orcid":false,"given":"Simon","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Turkez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Boren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9955-6003","authenticated-orcid":false,"given":"Jens","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Uhlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4254-6090","authenticated-orcid":false,"given":"Adil","family":"Mardinoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2020.101303_bib1","article-title":"Lack of reinfection in rhesus macaques infected with SARS-CoV-2","author":"Bao","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.isci.2020.101303_bib2","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 preliminary report","author":"Beigel","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2020.101303_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2020.101303_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.006","article-title":"Host-viral infection maps reveal signatures of severe COVID-19 patients","author":"Bost","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2020.101303_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/bib\/bbw110","article-title":"A review of validation strategies for computational drug repositioning","volume":"19","author":"Brown","year":"2018","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.isci.2020.101303_bib77","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2020.101303_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2020.101303_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2020.101303_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/22221751.2020.1732837","article-title":"Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity","volume":"9","author":"Chen","year":"2020","journal-title":"Emerging Microbes Infect."},{"key":"10.1016\/j.isci.2020.101303_bib9","article-title":"Historical parallels, Ebola virus disease and cholera: understanding community distrust and social violence with epidemics","volume":"8","author":"Cohn","year":"2016","journal-title":"PLoS Curr."},{"key":"10.1016\/j.isci.2020.101303_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J.\u00a0Crit. Care"},{"key":"10.1016\/j.isci.2020.101303_bib11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2020.101303_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bjp.0707306","article-title":"In silico pharmacology for drug discovery: applications to targets and beyond","volume":"152","author":"Ekins","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.isci.2020.101303_bib13","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.isci.2020.101303_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa330","article-title":"Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study","author":"Giacomelli","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2020.101303_bib15","article-title":"Severe acute respiratory syndrome-related coronavirus\u2013The species and its viruses, a statement of the Coronavirus Study Group","author":"Gorbalenya","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.isci.2020.101303_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2020.101303_bib17","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1093\/hmg\/ddw160","article-title":"Pathway and network-based strategies to translate genetic discoveries into effective therapies","volume":"25","author":"Greene","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2020.101303_bib18","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.isci.2020.101303_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2020.101303_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2020.101303_bib21","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1038\/sj.emboj.7601368","article-title":"A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus","volume":"25","author":"Imbert","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2020.101303_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from COVID-19 virus and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2020.101303_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2380-z","article-title":"Potent human neutralizing antibodies elicited by SARS-CoV-2 infection","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2020.101303_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2020.101303_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.isci.2020.101303_bib26","doi-asserted-by":"crossref","first-page":"11955","DOI":"10.1128\/JVI.02105-13","article-title":"Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors","volume":"87","author":"Kilianski","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2020.101303_bib27","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2020.101303_bib28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","article-title":"Tocilizumab for the treatment of chimeric antigen receptor T\u00a0cell-induced cytokine release syndrome","volume":"15","author":"Kotch","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.isci.2020.101303_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2020.101303_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.coi.2013.08.004","article-title":"Drug repurposing: a better approach for infectious disease drug discovery?","volume":"25","author":"Law","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2020.101303_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.isci.2020.101303_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.isci.2020.101303_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2020.101303_bib34","doi-asserted-by":"crossref","first-page":"taaa021","DOI":"10.1093\/jtm\/taaa021","article-title":"The reproductive number of COVID-19 is higher compared to SARS coronavirus","volume":"27","author":"Liu","year":"2020","journal-title":"J.\u00a0Trav. Med."},{"key":"10.1016\/j.isci.2020.101303_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.isci.2020.101303_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tips.2020.03.006","article-title":"Ongoing clinical trials for the management of the COVID-19 pandemic","volume":"41","author":"Lythgoe","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2020.101303_bib37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2020.101303_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00515-12","article-title":"Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines","volume":"3","author":"M\u00fcller","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.isci.2020.101303_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drudis.2018.06.012","article-title":"Renovation as innovation: is repurposing the future of drug discovery research?","volume":"24","author":"Neuberger","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2020.101303_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2020.101303_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ddstr.2011.10.002","article-title":"Drug repurposing from an academic perspective","volume":"8","author":"Oprea","year":"2011","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"10.1016\/j.isci.2020.101303_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4812","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2020.101303_bib43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tim.2015.11.008","article-title":"Pneumonic plague: the darker side of Yersinia pestis","volume":"24","author":"Pechous","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.isci.2020.101303_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fimmu.2019.00531","article-title":"Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a long-lived enemy","volume":"10","author":"Pizzorno","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2020.101303_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-4141-6","article-title":"Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients","volume":"21","author":"Pottecher","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.isci.2020.101303_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2020.101303_bib47","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication","volume":"105","author":"Ratia","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.isci.2020.101303_bib48","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJMc2001468","article-title":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","volume":"382","author":"Rothe","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.isci.2020.101303_bib49","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2020.101303_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt.2151","article-title":"Use of genome-wide association studies for drug repositioning","volume":"30","author":"Sanseau","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2020.101303_bib51","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2020.101303_bib52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.annepidem.2018.02.013","article-title":"A review of the 1918 herald pandemic wave: importance for contemporary pandemic response strategies","volume":"28","author":"Simonsen","year":"2018","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.isci.2020.101303_bib54","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2020.101303_bib55","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3201\/eid2606.200301","article-title":"Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China","volume":"26","author":"Tang","year":"2020","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.isci.2020.101303_bib56","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/nsr\/nwaa036","article-title":"On the origin and continuing evolution of SARS-CoV-2","volume":"7","author":"Tang","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.isci.2020.101303_bib57","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/v11040326","article-title":"Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir","volume":"11","author":"Tchesnokov","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2020.101303_bib58","article-title":"Systems biology based drug repositioning for development of cancer therapy","author":"Turanli","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.isci.2020.101303_bib59","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ebiom.2019.03.009","article-title":"Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning","volume":"42","author":"Turanli","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2020.101303_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2020.101303_bib61","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.25748","article-title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures","volume":"92","author":"Wang","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.isci.2020.101303_bib62","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2020.101303_bib63","series-title":"Bacille Calmette-Gu\u00e9rin (BCG) Vaccination and COVID-19: Scientific Brief, 12 April 2020","author":"WHO","year":"2020"},{"key":"10.1016\/j.isci.2020.101303_bib64","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jmv.25702","article-title":"Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary\/Review]","volume":"92","author":"Xiao","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.isci.2020.101303_bib65","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2020.101303_bib66","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s13238-018-0544-5","article-title":"Single-cell metagenomics: challenges and applications","volume":"9","author":"Xu","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.isci.2020.101303_bib67","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.02114-07","article-title":"Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design","volume":"82","author":"Xue","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.isci.2020.101303_bib68","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/infdis\/jiaa077","article-title":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period","volume":"221","author":"Yu","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2020.101303_bib69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.drudis.2019.12.009","article-title":"Multiscale modelling of drug mechanism and safety","volume":"25","author":"Zhang","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2020.101303_bib70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2020.101303_bib71","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory\u00a0drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.isci.2020.101303_bib72","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2020.101303_bib73","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2020.101303_bib74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2020.101303_bib75","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2020.101303_bib76","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004220304909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004220304909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:13:24Z","timestamp":1762877604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004220304909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2589004220304909"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2020.101303","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Status of COVID-19 Therapies and Drug Repositioning Applications","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2020.101303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101303"}}